Gene Query: HLA-DRA

Dataset Description Geneva Score
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 194.39
Transcription control by the ENL YEATS domain in acute leukemia 170.12
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 170.12
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 165.55
FOXP1 orchestration of ASD-relevant signaling pathways. 154.48
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 127.43
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 112.77
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 107.63
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 100.4
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 96.85
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 96.85
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 96.58
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 96.58
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 91.02
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 91.02
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 87.27
Pharmacologic inhibition of STAT5 in AML 79.78
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 79.09
Seletive inhibition of CDK9 in DLBCL cell lines 78.71
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 78.41
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 77.54
Targeting MTHFD2 in Acute Myeloid Leukemia 74.04
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 72.18
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 67.65
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 67.31
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 66.92
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 66.64
Inhibition of TNBC metastasis by Gpx1 66.26
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 63.89
Androgen Receptor-regulated genes in prostate cancer cells 63.89
Unique features and clinical importance of acute alloreactive immune responses 62.64
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 62.38
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 61.34
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 60.27
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 60.24
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 58.65
CHD1 regulates cell fate determination by activation of differentiation-induced genes 58.21
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 56.71
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 55.75
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 55.36
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 54.81
Transcriptome analysis of U87 cells upon LINC00152 knockdown 51.91
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 51.53
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 51.35
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 51.06
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 51.05
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 51.05
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 50.84
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 49.6
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 49.3
Fbxo32 mediated gene expression program underlies EMT and metastasis 48.86
Effect of disulfiram treatment on pediatric high grade glioma 48.72
Gene expression profile of multiple myeloma cell lines treated with CB-5083 47.97
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 47.96
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 47.92
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 47.39
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 47.34
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 46.62
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 46.43
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 46.38
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 45.16
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 44.94
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 44.2
MYCi975 regulates MYC target genes 43.87
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 43.33
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 43.33
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 43.08
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 42.98
Transcriptional effect of ETV1 knockdown in melanoma cells 41.8
Gene expression changes associated with resistance to tagraxofusp (SL-401) 41.42
The cytokine environment influence on human skin-derived T cells 40.38
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 39.94
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 39.87
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 39.85
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 38.96
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 38.84
Morphological and molecular characterization of human dermal lymphatic collectors 37.96
Transcriptional responses of melanoma cells to BRAF inhibition 37.6
MAIT cell RNA sequencing 37.15
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 37.08
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 36.95
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 36.95
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 36.43
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 36.14
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 36.06
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 35.88
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 35.63
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 35.62
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 35.6
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 35.13
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 34.85
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 34.79
Neonatal and adult human testis defined at the single-cell level 34.62
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 34.62
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 34.58
The pause-initiation limit restricts transcription activation in human cells 34.49
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 34.47
Regionally specified human pluripotent stem cell-derived astrocytes 34.39
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 33.16
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 32.9
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 32.73
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 32.53
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 32.42
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 32.39
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 32.38
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 32.16
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 31.81
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 31.58
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 31.21
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 31.06
A novel target of EZH1/2 for treatment of mantle cell lymphoma 30.95
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 30.37
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 30.22
Transcriptome of diurnal human blood neutrophils 30.0
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 29.86
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 29.42
Characterization of the Merkel cell carcinoma miRNome 29.14
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 29.0
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 29.0
Functional astrocytes differentiated from hiPSCs 28.98
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 28.96
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 28.88
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 28.65
Transcriptome analysis of virus infected tissues 28.52
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 28.49
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 28.37
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 28.04
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 27.56
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 27.47
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 27.47
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 27.1
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 26.83
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 26.66
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 26.53
Global analysis of alternative splicing regulated by RBM10 26.26
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 25.93
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 25.7
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 25.7
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 25.56
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 25.33
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 25.33
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 25.24
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 25.24
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 24.58
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 24.26
An acquired vulnerability of drug resistant melanoma with therapeutic potential 24.19
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 24.19
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 24.11
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 24.1
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 23.91
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 23.9
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 23.72
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 23.63
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 23.54
CircRNAome diversity in human mature B-cells, T-cells and monocytes 23.53
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 23.5
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 23.42
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 23.04
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 22.99
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 22.96
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 22.83
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  22.71
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 22.65
Proteomics identifies a marker signature of MAPKi resistance in melanoma 22.3
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 22.04
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 21.99
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 21.96
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 21.81
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 21.81
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 21.72
Aortic Valve Tissue: Stenosis vs. Sclerosis 21.7
Expression by CD133+ cells isolated from the adult human exocrine pancreas 21.68
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 21.66
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 21.65
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 21.53
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 21.53
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 21.46
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 21.3
Short and Long RNA sequencing of human mature erythrocytes 21.28
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 21.25
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 21.24
Human Treg NaCl stimulation 20.92
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 20.69
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 20.59
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 20.3
Trans-differentiation of human adult peripheral blood T cells into neurons 19.85
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 19.72
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 19.46
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 19.46
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 19.45
SRSF2 mutations impair hematopoiesis and alter exon recognition 19.45
The transcriptome of Kawasaki Disease arteritis 19.43
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 19.31
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 19.17
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 19.13
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 19.13
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 19.07
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 19.07
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 19.05
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 19.05
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 18.27
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 18.21
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 18.05
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 18.04
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 17.99
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 17.96
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 17.93
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 17.91
Gene expression changes in human melanoma cell lines compared to primary melanocytes 17.89
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 17.81
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 17.63
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 17.63
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 17.62
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 17.51
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 17.49
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 17.41
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 17.39
GATA3-mediated chromatin reprogramming in breast cancer cells 17.34
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 17.23
Identification of renal resident macrophages across species [C1] 17.06
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 17.05
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 16.99
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 16.57
Transcriptional profiling of microglia; current state of the art and future perspectives 16.45
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 16.27
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 15.94
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 15.75
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 15.75
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 15.71
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 15.64
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 15.54
Differential responses of human fetal brain neural stem cells to Zika virus infection 15.49
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 15.48
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 15.42
RNA-seq of MDA-MB-231 cells with TET1 knockout 15.27
RNA-Seq from human ILC transitional populations 15.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 15.09
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 15.0
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 14.98
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 14.82
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 14.33
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 14.32
The DNA methylation landscape of human melanoma [RNA-Seq] 14.25
The DNA methylation landscape of human melanoma 14.25
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 14.18
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 14.17
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 14.17
RNA seq comparison between scrambled and shGRP78 cells 14.12
The Glioma-Infiltrating T Cell Receptor Repertoire 14.06
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 13.94
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 13.83
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 13.69
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 13.69
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 13.68
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 13.64
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 13.56
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 13.47
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 13.43
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 13.39
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 13.33
Primary human trophoblast from term placenta 13.22
Global gene expression profile of dasatinib-resistant RCH-ACV cells 13.15
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 13.12
RNA-sequencing of human tendon after injury 13.11
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 12.78
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 12.78
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 12.78
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 12.75
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 12.71
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 12.62
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 12.62
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 12.57
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 12.52
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 12.5
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 12.44
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 12.41
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 12.41
Hepatocyte maturation 12.34
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 12.26
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 12.07
Microglia innatly develop within cerebral organoids 11.94
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 11.92
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 11.86
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 11.71
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 11.67
Transciptomic profiling of human fetal lung samples 11.65
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 11.56
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 11.49
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 11.46
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 11.43
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 11.41
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 11.39
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 11.39
RNA sequencing with KSHV infection and enrichment for circular RNAs 11.38
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 11.34
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 11.3
RNA-seq in endometrial stromal tumors 11.26
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 11.24
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 11.24
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 11.22
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 11.14
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 11.01
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 10.95
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 10.93
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 10.87
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 10.84
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 10.82
Efficient derivation of microglia-like cells from human pluripotent stem cells 10.55
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 10.54
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 10.54
Dilated cardiomyopathy vs Myocarditis 10.53
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 10.51
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 10.42
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 10.36
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 10.27
Generation and persistence of human tissue-resident memory T cells in lung transplantation 10.22
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 10.18
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 10.17
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 10.17
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 9.84
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.79
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 9.74
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 9.68
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 9.65
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.54
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 9.51
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 9.51
Identification of renal resident macrophages across species 9.48
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 9.42
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 9.42
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 9.29
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 9.21
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 9.11
Human Treg IL-12 stimulation 9.08
The role of CFTR in islet function 8.9
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 8.9
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.83
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 8.83
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 8.78
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 8.53
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 8.48
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 8.44
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 8.43
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 8.34
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 8.34
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 8.26
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 8.21
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 8.15
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 8.15
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 8.03
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.95
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 7.62
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 7.54
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 7.48
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 7.45
RNA sequencing of human pancreatic cancer cell lines 7.4
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 7.18
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.13
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 7.05
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 6.88
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 6.8
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 6.8
RNA-seq data 6.76
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 6.36
Gene expression signatures of innate lymphoid cells from human blood 6.34
Human Treg IFNg/IL-10 subpopulations 6.34
Gene expression profile in breast cancer cell lines using RNA sequencing 6.21
Genome-wide identification of cancer-specific alternative splicing in circRNA 6.1
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 6.01
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 6.01
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 6.01
RNA-Seq analysis of human colorectal cancer with liver metastasis 5.87
Loss of endometrial plasticity in recurrent pregnancy loss 5.85
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 5.85
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.73
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.59
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.52
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 5.51
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 5.47
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 5.44
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 5.37
Impact on erythroid progenitor type on erythroid differntiation 5.32
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.25
Gene expression analysis of human liver progenitor-like cells in culture 5.12
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.01
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.01
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.86
Alagille_Nodder 4.82
RNA Seq of Alagille liver biopsies 4.82
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 4.52
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 4.52
Common inflammatory pathways between NEC and Crohn's disease 4.5
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.49
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.42
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 4.4
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 4.4
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.4
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.4
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 4.37
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 4.32
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 4.29
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.28
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.28
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 4.17
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.17
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.17
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 4.13
Measure transcript integrity using RNA-seq data 3.99
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.91
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 3.83
Transcriptome profiling of 5 human adenocarcinoma cell lines 3.77
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 3.75
Leucegene: ALL sequencing 3.75
Analyses of T-ALL (COG study) 3.73
RNA sequencing of T-ALL (COG study) 3.73
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.67
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 3.67
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 3.59
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.57
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.49
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.49
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 3.37
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 3.28
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 3.26
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.25
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 3.25
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 3.21
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 3.14
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 3.12
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 2.99
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.98
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.95
Age-Related Gene Expression Changes in Prostate Cancer Patients 2.95
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 2.95
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.93
circRNA profile in hypopharyngeal cancer 2.92
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.8
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.79
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 2.73
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.68
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.67
Global epigenomic reconfiguration during mammalian brain development 2.67
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 2.63
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.57
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 2.56
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 2.53
RNAseq in Alzheimer's Disease patients 2.47
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.35
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.35
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 2.29
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 2.27
RNA expression profiles comparing primary and omental ovarian carcinoma samples 2.23
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 2.21
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.18
Fibroblasts in cholesteatoma activate osteoclasts. 2.18
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.17
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.14
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.11
RNA-seq of cells with TET1 knockout 2.09
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.95
Gene expression alterations of pancreatic intraepithlial neoplasia 1.93
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 1.85
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.82
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 1.73
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.66
naive T cell heterogeneity after neonatal thymectomy 1.57
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.53
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.52
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.29
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.21
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.11
Hepatic transcriptome of pediatric hepatoblastoma. 1.11
Gene expression analysis of human adenomas. 1.1
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.06
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 1.06
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.01
Leucegene: AML sequencing (part 6) 0.88
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.84
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.76
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.74
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 0.72
RNA-seq analysis of the human fetal kidney. 0.68
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.66
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.66
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.57
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.55
CUREfast: Accelerating research with families 0.51
CD86 regulates a pro-survival signal in myeloma cells 0.4
Human ovarian granulosa cell transcriptome 0.38
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.27
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.27
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.26
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.23
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.22
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.17
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.17
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.14
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.12
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.08
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation